These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Nikiforova MN; Nikiforov YE Expert Rev Mol Diagn; 2008 Jan; 8(1):83-95. PubMed ID: 18088233 [TBL] [Abstract][Full Text] [Related]
27. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403 [TBL] [Abstract][Full Text] [Related]
28. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523 [TBL] [Abstract][Full Text] [Related]
29. Molecular diagnosis of carcinomas of the thyroid gland. de Biase D; Visani M; Pession A; Tallini G Front Biosci (Elite Ed); 2014 Jan; 6(1):1-14. PubMed ID: 24389136 [TBL] [Abstract][Full Text] [Related]
30. Detection of the PAX8-PPARgamma fusion protein in thyroid tumors. Koenig RJ Clin Chem; 2010 Mar; 56(3):331-3. PubMed ID: 20075182 [No Abstract] [Full Text] [Related]
31. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Zhu Z; Gandhi M; Nikiforova MN; Fischer AH; Nikiforov YE Am J Clin Pathol; 2003 Jul; 120(1):71-7. PubMed ID: 12866375 [TBL] [Abstract][Full Text] [Related]
32. Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR. Klemke M; Drieschner N; Belge G; Burchardt K; Junker K; Bullerdiek J Genes Chromosomes Cancer; 2012 Apr; 51(4):402-8. PubMed ID: 22179975 [TBL] [Abstract][Full Text] [Related]
33. Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene. Lui WO; Foukakis T; Lidén J; Thoppe SR; Dwight T; Höög A; Zedenius J; Wallin G; Reimers M; Larsson C Oncogene; 2005 Feb; 24(8):1467-76. PubMed ID: 15608688 [TBL] [Abstract][Full Text] [Related]
34. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876 [TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of thyroid tumors. Nikiforov YE Mod Pathol; 2011 Apr; 24 Suppl 2():S34-43. PubMed ID: 21455199 [TBL] [Abstract][Full Text] [Related]
36. BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Goutas N; Vlachodimitropoulos D; Bouka M; Lazaris AC; Nasioulas G; Gazouli M Anticancer Res; 2008; 28(1A):305-8. PubMed ID: 18383861 [TBL] [Abstract][Full Text] [Related]
37. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937 [TBL] [Abstract][Full Text] [Related]
38. Genetic alterations in N-bis(2-hydroxypropyl)nitrosamine-induced rat transplantable thyroid carcinoma lines: analysis of the TSH-R, G(alpha)s, ras and p53 genes. Kitahori Y; Naitoh H; Konishi N; Ohnishi T; Hiasa Y Carcinogenesis; 1997 Feb; 18(2):265-9. PubMed ID: 9054617 [TBL] [Abstract][Full Text] [Related]